LONP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.845000E-01
Normal-vs-Stage2
6.381600E-01
Normal-vs-Stage3
1.793820E-01
Normal-vs-Stage4
1.090230E-01
Stage1-vs-Stage2
9.661400E-01
Stage1-vs-Stage3
1.272210E-01
Stage1-vs-Stage4
8.058000E-02
Stage2-vs-Stage3
7.527800E-02
Stage2-vs-Stage4
4.596700E-03
Stage3-vs-Stage4
2.066500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.171800E-01
Normal-vs-AfricanAmerican
3.522600E-01
Normal-vs-Asian
8.837400E-01
Caucasian-vs-AfricanAmerican
2.730200E-01
Caucasian-vs-Asian
7.636800E-01
AfricanAmerican-vs-Asian
3.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.868000E-01
Normal-vs-Female
6.832600E-01
Male-vs-Female
9.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.628800E-01
Normal-vs-Age(41-60Yrs)
4.080600E-01
Normal-vs-Age(61-80Yrs)
8.179800E-01
Normal-vs-Age(81-100Yrs)
9.630000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.139600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.273000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.391800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.643500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.565650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.603000E-01
Normal-vs-Daily Drinker
7.365800E-01
Normal-vs-Weekly Drinker
9.635600E-01
Normal-vs-Occasional Drinker
2.739400E-01
Normal-vs-Social Drinker
5.421200E-01
Non Drinker-vs-Daily Drinker
1.775430E-01
Non Drinker-vs-Weekly Drinker
5.424000E-01
Non Drinker-vs-Occasional Drinker
5.641900E-02
Non Drinker-vs-Social Drinker
6.806400E-01
Daily Drinker-vs-Weekly Drinker
6.527600E-01
Daily Drinker-vs-Occasional Drinker
6.219900E-03
Daily Drinker-vs-Social Drinker
1.126840E-01
Weekly Drinker-vs-Occasional Drinker
6.133800E-02
Weekly Drinker-vs-Social Drinker
3.881000E-01
Occasional Drinker-vs-Social Drinker
1.709010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.841900E-02
Normal-vs-Grade 2
3.062600E-03
Normal-vs-Grade 3
1.901140E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.775950E-02
Grade 1-vs-Grade 3
2.119800E-03
Grade 1-vs-Grade 4
4.841900E-02
Grade 2-vs-Grade 3
1.343150E-01
Grade 2-vs-Grade 4
3.062600E-03
Grade 3-vs-Grade 4
1.901140E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.935400E-01
Normal-vs-NonDiabetic
7.657000E-01
Diabetic-vs-NonDiabetic
9.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.059600E-01
Normal-vs-NoPancreatitis
7.570000E-01
Pancreatitis-vs-NoPancreatitis
8.302600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.111200E-01
Normal-vs-N1
6.399200E-01
N0-vs-N1
7.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.010800E-01
Normal-vs-TP53-NonMutant
8.206800E-01
TP53-Mutant-vs-TP53-NonMutant
7.742800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
